Global Pharmaceutical Manufacturing Market Size & Outlook

The pharmaceutical manufacturing industry worldwide is expected to reach a projected revenue of US$ 913,650.8 million by 2030. A compound annual growth rate of 8.9% is expected of the worldwide pharmaceutical manufacturing industry from 2024 to 2030.

Revenue, 2023 (US$M)
$503,419.9
Forecast, 2030 (US$M)
$913,650.8
CAGR, 2024 - 2030
8.9%
Report Coverage
Worldwide

Global pharmaceutical manufacturing market, 2018-2030 (US$M)

Global pharmaceutical manufacturing market highlights

  • The global pharmaceutical manufacturing market generated a revenue of USD 503,419.9 million in 2023 and is expected to reach USD 913,650.8 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8.9% by 2030.
  • In terms of segment, conventional drugs (small molecules) accounted for a revenue of USD 273,802.0 million in 2023.
  • Conventional Drugs (Small Molecules) is the most lucrative molecule type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 503,419.9 million
Market revenue in 2030USD 913,650.8 million
Growth rate8.9% (CAGR from 2023 to 2030)
Largest segmentConventional drugs (small molecules)
Fastest growing segmentConventional Drugs (Small Molecules)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)

Other key industry trends

  • In terms of revenue, the North America accounted for 41.3% of the global pharmaceutical manufacturing market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 355.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical Manufacturing Market Scope

Pharmaceutical manufacturing market segmentation & scope
Monoclonal Antibodies
Vaccines
Cell & Gene Therapy
Others
Conventional Drugs (Small Molecules)
Outsource
In-house
Tablets
Capsules
Injectables
Sprays
Suspensions
Powders
Other Formulations
Oral
Topical
Parenterals
Inhalations
Other Routes of Administration
Cardiovascular Diseases
Pain
Diabetes
Cancer
Respiratory Diseases
Other Diseases
Prescription Medicines
Over-the-counter (OTC) Medicines
Children & Adolescents
Adults
Geriatric
Retail
Non-retail

Pharmaceutical Manufacturing Market Companies

Name Profile # Employees HQ Website

Global pharmaceutical manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.


conventional drugs (small molecules) was the largest segment with a revenue share of 54.39% in 2023. Horizon Databook has segmented the Global pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Million, 2018-2030)
    • Biologics & Biosimilars (Large Molecules)
      • Monoclonal Antibodies
      • Vaccines
      • Cell & Gene Therapy
      • Others
    • Conventional Drugs (Small Molecules)
  • Global Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Million, 2018-2030)
    • Outsource
    • In-house
  • Global Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Million, 2018-2030)
    • Tablets
    • Capsules
    • Injectables
    • Sprays
    • Suspensions
    • Powders
    • Other Formulations
  • Global Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Oral
    • Topical
    • Parenterals
    • Inhalations
    • Other Routes of Administration
  • Global Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Million, 2018-2030)
    • Cardiovascular Diseases
    • Pain
    • Diabetes
    • Cancer
    • Respiratory Diseases
    • Other Diseases
  • Global Pharmaceutical Manufacturing Prescription Requirements Outlook (Revenue, USD Million, 2018-2030)
    • Prescription Medicines
    • Over-the-counter (OTC) Medicines
  • Global Pharmaceutical Manufacturing Age Type Outlook (Revenue, USD Million, 2018-2030)
    • Children & Adolescents
    • Adults
    • Geriatric
  • Global Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Million, 2018-2030)
    • Retail
    • Non-retail

Reasons to subscribe to Global pharmaceutical manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global pharmaceutical manufacturing market databook

  • Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global pharmaceutical manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global pharmaceutical manufacturing market statistics, by regions, 2018-2030 (US$M)

Top 10 countries: Pharmaceutical manufacturing market size, 2023 (USD Million)

Top 10 countries: Pharmaceutical manufacturing market size, 2023 (USD Million)

Global pharmaceutical manufacturing market, by region, 2023 (US$M)

Global pharmaceutical manufacturing market statistics, by regions, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more